Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells

Surgery

Volumn 142, Issue 2, 2007, Pages 163-169

  Takami, Yoji ^a   Russell, Michael B ^b   Gao, Chengjiang ^b   Mi, Zhiyong ^b   Guo, Hongtao ^b   Mantyh, Christopher R ^b   Kuo, Paul C ^b  

^a CHIBA UNIVERSITY   (Japan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; OSTEOPONTIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION REGULATION; UPREGULATION;

ADENOCARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOPONTIN; PROMOTER REGIONS (GENETICS); RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR;

EID: 34547612537     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.02.015     Document Type: Article

References (23)

1. Senger D.R., Perruzzi C.A., Gracey C.F., Papadopoulos A., and Tenen D.G. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48 (1988) 5770-5774
2. Bellahcene A., and Castronovo V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146 (1995) 95-100
3. Singhal H., Bautista D.S., Tonkin K.S., O'Malley F.P., Tuck A.B., Chambers A.F., et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 3 (1997) 605-611
4. Casson A.G., Wilson S.M., McCart J.A., O'Malley F.P., Ozcelik H., Tsao M.S., et al. ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer. Int J Cancer 72 (1997) 739-745
5. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94 (2002) 513-521
6. Coppola D., Szabo M., Boulware D., Muraca P., Alsarraj M., Chambers A.F., et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10 (2004) 184-190
7. Wai P.Y., Mi Z., Guo H., Sarraf-Yazdi S., Gao C., Wei J., et al. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Carcinogenesis 26 (2005) 741-751
8. Wai P.Y., Mi Z., Gao C., Guo H., Marroquin C., and Kuo P.C. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 281 (2006) 18973-18982
9. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics, 1996. CA Cancer J Clin 46 (1996) 5-27
10. Martin R., Paty P., Fong Y., Grace A., Cohen A., DeMatteo R., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197 (2003) 233-241
11. Scheele J., Stangl R., Altendorf-Hofmann A., and Gall F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 (1991) 13-29
12. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 4 (2004) 448-456
13. Ahmad S.A., Berman R.S., and Ellis L.M. Biology of colorectal liver metastases. Surg Oncol Clin N Am 12 (2003) 135-150
14. Berman R.S., Portera Jr. C.A., and Ellis L.M. Biology of liver metastases. Cancer Treat Res 109 (2001) 183-206
15. Brown L.F., Papadopoulos-Sergiou A., Berse B., Manseau E.J., Tognazzi K., Perruzzi C.A., et al. Osteopontin expression and distribution in human carcinomas. Am J Pathol 145 (1994) 610-623
16. Gotoh M., Sakamoto M., Kanetaka K., Chuuma M., and Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 52 (2002) 19-24
17. Smith J.H., and Denhardt D.T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem 34 (1987) 13-22
18. Craig A.M., and Denhardt D.T. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 100 (1991) 163-171
19. Denhardt D.T., and Guo X.J. Osteopontin: a protein with diverse functions. FASEB J 7 (1993) 1475-1482
20. Hijiya N., Setoguchi M., Matsuura K., Higuchi Y., Akizuki S., and Yamamoto S. Cloning and characterization of the human osteopontin gene and its promoter. Biochem J 303 (1994) 255-262
21. Malyankar U.M., Hanson R., Schwartz S.M., Ridall A.L., and Giachelli C.M. Upstream stimulatory factor 1 regulates osteopontin expression in smooth muscle cells. Exp Cell Res 250 (1999) 535-547
22. Zhang Q., Wrana J.L., and Sodek J. Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter. Eur J Biochem 207 (1992) 649-659
23. Safe S., and Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 41 (2005) 2438-2448